Quick Answer
InspireMD, Inc. reported Research And Development Expense of $15.00 million for the year ending 2025.
- InspireMD, Inc. showed an increase of +10.0% in Research And Development Expense from 2024 to 2025.
- This data is from InspireMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $547.0 thousand | Q4 2011: $834.0 thousand | Q1 2012: $1.35 million | Q3 2012: $946.0 thousand | Q4 2012: $1.26 million | Q1 2013: $907.0 thousand | Q2 2013: $1.05 million | Q3 2013: $1.54 million | Q1 2014: $2.58 million | Q2 2014: $2.45 million | Q3 2014: $2.46 million | Q1 2015: $1.35 million | Q2 2015: $747.0 thousand | Q3 2015: $781.0 thousand | Q1 2016: $379.0 thousand | Q2 2016: $278.0 thousand | Q3 2016: $289.0 thousand | Q1 2017: $350.0 thousand | Q2 2017: $403.0 thousand | Q3 2017: $288.0 thousand | Q1 2018: $252.0 thousand | Q2 2018: $230.0 thousand | Q3 2018: $416.0 thousand | Q1 2019: $1.13 million | Q2 2019: $865.0 thousand | Q3 2019: $442.0 thousand | Q1 2020: $523.0 thousand | Q2 2020: $444.0 thousand | Q3 2020: $546.0 thousand | Q1 2021: $839.0 thousand | Q2 2021: $1.29 million | Q3 2021: $1.50 million | Q1 2022: $1.68 million | Q2 2022: $2.06 million | Q3 2022: $2.06 million | Q1 2023: $1.84 million | Q2 2023: $1.99 million | Q3 2023: $2.11 million | Q1 2024: $2.63 million | Q2 2024: $3.40 million | Q3 2024: $3.92 million | Q1 2025: $4.06 million | Q2 2025: $3.83 million | Q3 2025: $3.64 million.
- Over the full 17 years of available data (2009 to 2025), InspireMD, Inc.'s Research And Development Expense has grown by 1,028.0%.
- Historical annual values: Fiscal year 2025: $15.00 million | Fiscal year 2024: $13.63 million | Fiscal year 2023: $7.98 million | Fiscal year 2022: $7.81 million | Fiscal year 2021: $5.16 million | Fiscal year 2020: $2.23 million | Fiscal year 2019: $2.95 million | Fiscal year 2018: $1.54 million | Fiscal year 2017: $1.28 million | Fiscal year 2016: $1.29 million | Fiscal year 2015: $3.64 million | Fiscal year 2014: $8.74 million | Fiscal year 2013: $4.16 million | Fiscal year 2012: $3.99 million | Fiscal year 2011: $2.47 million | Fiscal year 2010: $1.34 million | Fiscal year 2009: $1.33 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: